Additional Acquisitions: #Visma > #WeFact; #WorkWise > #Bizhaven

Agreed Acquisitions: #Asurion > #Domestic&General; #Hims&HersHealth > #YourBioHealth; #IBM > #Confluent; #MirumPharmaceuticals > #BluejayTherapeutics; #L’Oreal > #GaldermaGroup

IPO: #LumexaImaging raised $462.5M

Bluejay begins phase 3 trial of brelovitug for hepatitis D - PharmaTimes First patient enrolled in AZURE-2 study comparing brelovitug to Hepcludex

#Bluejay #BluejayTherapeutics #phase3trial #brelovitug #BJT778 #hepatitisD #AZURE2study #CHD #hepatitisDvirus #cirrhosis #livercancer #viralhepatitis #liverdisease #BreakthroughTherapydesignation #FDA #PRIMEdesignation #Orphanstatus #OrphanDrug #EMA
pharmatimes.com/news/bluejay...